 NIVOLUMAB IN COMBINATION WITH IPILIMUMAB PART 1; NIVOLUMAB PLUS IPILIMUMAB IN COMBINATION WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE PART 2 AS FIRST LINE THERAPY IN STAGE IV NON-SMALL CELL LUNG CANCER: 